Patients With Type 2 Diabetes Mellitus and Heart Failure Benefit More From Sodium-Glucose Cotransporter 2 Inhibitor: A Systematic Review and Meta-Analysis

BACKGROUND: Patients with type 2 diabetes mellitus (T2DM) and heart failure (HF) are at higher risk of mortality and hospitalization for heart failure (HHF). A recent study showed that sodium-glucose cotransporter 2 (SGLT-2) inhibitors may be a promising choice. METHODS: We searched the PubMed, Emba...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chengcong, Peng, Hong, Li, Mingzhu, Lu, Xiyan, Huang, Miao, Zeng, Yongmei, Dong, Guoqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572881/
https://www.ncbi.nlm.nih.gov/pubmed/34759887
http://dx.doi.org/10.3389/fendo.2021.664533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572881/
https://www.ncbi.nlm.nih.gov/pubmed/34759887
http://dx.doi.org/10.3389/fendo.2021.664533

Ejemplares similares